Skip to main content

Search Videos and More

Showing 1 - 16 of 117 results

Previous| 1 | 2 | 3 ...8 |Next

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing

After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

Mount Sinai Study Shows Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

Mount Sinai Study Shows Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

Roxana Mehran, MD, Is Incoming Vice President of the American College of Cardiology

Roxana Mehran, MD, Is Incoming Vice President of the American College of Cardiology

Mount Sinai-led Study on Pulsed Field Ablation Procedures Demonstrate Significant Safety Outcomes for Atrial Fibrillation Patients

Mount Sinai-led Study on Pulsed Field Ablation Procedures Demonstrate Significant Safety Outcomes for Atrial Fibrillation Patients

Mount Sinai Fuster Heart Hospital: 2023 Clinical Outcomes and Innovations Report

Mount Sinai Fuster Heart Hospital: 2023 Clinical Outcomes and Innovations Report

New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received Prestigious Award From World Heart Federation

Valentín Fuster, MD, PhD, MACC, President of Mount Sinai Fuster Heart Hospital, Received Prestigious Award From World Heart Federation

Celebrating Dr. Valentín Fuster's Contributions to Cardiovascular Medicine and Science

Celebrating Dr. Valentín Fuster's Contributions to Cardiovascular Medicine and Science

Stopping Aspirin One Month After Coronary Stenting Procedures Significantly Reduces Bleeding Complications in Heart Attack Patients

Stopping Aspirin One Month After Coronary Stenting Procedures Significantly Reduces Bleeding Complications in Heart Attack Patients

ACC Cardiology Hour From ACC.24

ACC Cardiology Hour From ACC.24

Quantitative Prediction of Right Ventricular Problems May Transform Congenital Heart Disease Outcomes

Quantitative Prediction of Right Ventricular Problems May Transform Congenital Heart Disease Outcomes

Showing 1 - 16 of 117 results

Previous| 1 | 2 | 3 ...8 |Next